# Baxter agrees to acquire RECOTHROM and PREVELEAK from Mallinckrodt

Baxter International announced an agreement to acquire two hemostat and sealant products, RECOTHROM and PREVELEAK, from Mallinckrodt plc to broaden its surgical portfolio.

- Type: Acquisition
- Announced: 2018-01-08
- Where: United States
- Value: $185.0M
- Status: announced
- Products: RECOTHROM Thrombin topical, PREVELEAK Surgical Sealant
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Baxter International](https://endata.com/companies/20761.md) (acquirer)
- [Mallinckrodt plc](https://endata.com/companies/29248.md) (target)

## Sources

- [baxter.be](https://www.baxter.be/en/baxter-newsroom/baxter-announces-agreement-broaden-portfolio-innovative-surgical-products), 2018-01-08: "Baxter International Inc. ... announced an agreement to acquire two hemostat and sealant products from Mallinckrodt plc."
- [prnewswire.com](https://www.prnewswire.com/news-releases/mallinckrodt-will-sell-recothrom-and-preveleak-to-baxter-300578756.html), 2018-01-08: "Mallinckrodt plc ... announced today it has entered into an agreement under which it will sell certain hemostasis products to Baxter International Inc. for approximately $185 million."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.